Supramolecular assemblies in functional siRNA delivery: where do we stand?

HM Aliabadi, B Landry, C Sun, T Tang, H Uludağ - Biomaterials, 2012 - Elsevier
The discovery of RNA interference (RNAi) has excited the scientific field due to its potential
for wide range of therapeutic applications. The pharmacological mediator of RNAi, short …

Prediction of amphiphilic cell-penetrating peptide building blocks from protein-derived amino acid sequences for engineering of drug delivery nanoassemblies

G Feger, B Angelov, A Angelova - The Journal of Physical …, 2020 - ACS Publications
Amphiphilic molecules, forming self-assembled nanoarchitectures, are typically composed
of hydrophobic and hydrophilic domains. Peptide amphiphiles can be designed from two …

A survey on “Trojan Horse” peptides: opportunities, issues and controlled entry to “Troy”

NQ Shi, XR Qi, B Xiang, Y Zhang - Journal of controlled release, 2014 - Elsevier
Abstract Cell-penetrating peptides (CPPs), often vividly termed as the “Trojan Horse”
peptides, have attracted considerable interest for the intracellular delivery of a wide range of …

[HTML][HTML] Materials promoting viral gene delivery

K Kaygisiz, CV Synatschke - Biomaterials Science, 2020 - pubs.rsc.org
Therapeutic viral gene delivery is an emerging technology which aims to correct genetic
mutations by introducing new genetic information to cells either to correct a faulty gene or to …

[HTML][HTML] Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities

T Knak, MA Abdullaziz, S Höfmann, LA Alves Avelar… - Pharmaceuticals, 2022 - mdpi.com
To address the continued rise of multi-drug-resistant microorganisms, the development of
novel drugs with new modes of action is urgently required. While humans biosynthesize the …

Self-assembly into nanoparticles is essential for receptor mediated uptake of therapeutic antisense oligonucleotides

K Ezzat, Y Aoki, T Koo, G McClorey, L Benner… - Nano …, 2015 - ACS Publications
Antisense oligonucleotides (ASOs) have the potential to revolutionize medicine due to their
ability to manipulate gene function for therapeutic purposes. ASOs are chemically modified …

A non-covalent peptide-based carrier for in vivo delivery of DNA mimics

MC Morris, E Gros, G Aldrian-Herrada… - Nucleic acids …, 2007 - academic.oup.com
The dramatic acceleration in identification of new nucleic-acid-based therapeutic molecules
has provided new perspectives in pharmaceutical research. However, their development is …

[HTML][HTML] Advances in peptide-mediated cytosolic delivery of proteins

M Sánchez-Navarro - Advanced Drug Delivery Reviews, 2021 - Elsevier
The number of protein-based drugs is exponentially increasing. However, development of
protein therapeutics against intracellular targets is hampered by the lack of efficient cytosolic …

Liposomal cancer therapy: exploiting tumor characteristics

T Kaasgaard, TL Andresen - Expert opinion on drug delivery, 2010 - Taylor & Francis
Importance of the field: More than 10 million people worldwide are diagnosed with cancer
each year, and the development of effective cancer treatments is consequently of great …

Bypassing the need for cell permeabilization: nanobody CDR3 peptide improves binding on living bacteria

A Breine, K Van Holsbeeck, C Martin… - Bioconjugate …, 2023 - ACS Publications
Membrane interaction constitutes to be an essential parameter in the mode of action of
entities such as proteins, as well as cell-penetrating and antimicrobial peptides, resulting in …